We are proud to announce the publication of our fully digital and interactive annual report 2020. In 2020 EU-OPENSCREEN reached several important milestones and became truly operational. We achieved…
EU-OPENSCREEN will be present at this year´s ADTCA 2021 which brings together groundbreaking Data Technologies, and derived products and services which have the potential to greatly influence the…
The EU-OPENSCREEN-DRIVE Chemoproteomics and Mass Spectrometry Imaging (MSI) Call 2021 aims at increasing the understanding of mechanisms of action by which a tool or small molecule hit/lead compound…
On May 11, our partner Petr Bartunek, Coordinator of CZ-OPENSCREEN, will chair the Workshop 'Research Infrastructures mobilisation in response to COVID-19: lessons learned', which is co-organised by…
Our partner site Fraunhofer ITMP in Hamburg was involved in a large research project with more than 100 partners. In order to find drug candidates against SARS-CoV-2, the consortium performed a…
In the frame of the Horizon2020 projects ACCELERATE and the ERIC Forum Implementation Project, the event ”Planning for Sustainability of Research Infrastructures” will be held online on 25 May 2021.
EU-OPENSCREEN-DRIVE (grant agreement No.823893) offers trans-national access to target-based and phenotype-based workflows, proteomics and related advanced mass spectrometry-based technologies, with a…
Compound repurposing is an important strategy for the identification of effective treatment options against SARS-CoV-2 infection and COVID-19 disease.The EU-OPENSCREEN high capacity screening partner…
If you are interested in 3D in vitro models and drug discovery do not miss our recent publication “Academic collaborative models fostering the translation of physiological in vitro systems from basic…
It is our pleasure to welcome you to the European Chemical Biology Symposium (ECBS) 2021, May 26-28, which is jointly organised by EU-OPENSCREEN and the EuChemS Division of Chemistry for Life Sciences…
